Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

586 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Complications, Visual Acuity, and Refractive Error Three Years After Secondary Intraocular Lens implantation for Pediatric Aphakia.
Wang S, Repka MX, Sutherland DR, Hatt SR, Traboulsi EI, Lambert SR, Melia BM, Kraker RT, Holmes JM, Cotter SA; Pediatric Eye Disease Investigator Group. Wang S, et al. Among authors: repka mx. Ophthalmology. 2024 May 14:S0161-6420(24)00301-4. doi: 10.1016/j.ophtha.2024.05.011. Online ahead of print. Ophthalmology. 2024. PMID: 38754556
Myths in Myopia Epidemiology and Treatment.
Lanca C, Repka MX, Grzybowski A. Lanca C, et al. Among authors: repka mx. JAMA Ophthalmol. 2024 May 1;142(5):403-404. doi: 10.1001/jamaophthalmol.2024.0575. JAMA Ophthalmol. 2024. PMID: 38573627
Refractive Error Change and Overminus Lens Therapy for Childhood Intermittent Exotropia.
Writing Committee for the Pediatric Eye Disease Investigator Group; Pediatric Eye Disease Investigator Group; Chen AM, Erzurum SA, Chandler DL, Hercinovic A, Wu R, Vricella M, Waters AL, Ticho BH, Erickson JW, Han S, McDowell PS, Li Z, Kraker RT, Holmes JM, Cotter SA. Writing Committee for the Pediatric Eye Disease Investigator Group, et al. JAMA Ophthalmol. 2024 May 1;142(5):417-428. doi: 10.1001/jamaophthalmol.2024.0276. JAMA Ophthalmol. 2024. PMID: 38536764 Clinical Trial.
Formulation and evaluation of inhaled Sildenafil-loaded PLGA microparticles for treatment of pulmonary arterial hypertension (PAH): A novel high drug loaded formulation and scalable process via hot melt extrusion technology (Part Ⅰ).
Almutairi M, Hefnawy A, Almotairy A, Alobaida A, Alyahya M, Althobaiti A, Adel Ali Youssef A, Elkanayati RM, Ashour EA, Smyth HDC, Repka MA. Almutairi M, et al. Among authors: repka ma. Int J Pharm. 2024 Apr 25;655:124044. doi: 10.1016/j.ijpharm.2024.124044. Epub 2024 Mar 23. Int J Pharm. 2024. PMID: 38527563
586 results